Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Tegal Corporation Reports Second Quarter Fiscal 2009 Financial Results

Abstract:
Tegal Corporation, a leading designer and manufacturer of plasma etch and deposition systems used in the production of integrated circuits and nanotechnology devices, today announced financial results for the Second Quarter Fiscal Year 2009, which ended September 30, 2008. Senior management will conduct an investor conference call to discuss these results and the company's financial outlook in more detail today at 2pm Pacific Time, Thursday, November 13, 2008. More information about the conference call is provided below.

Tegal Corporation Reports Second Quarter Fiscal 2009 Financial Results

Petaluma, CA | Posted on November 13th, 2008

Second Quarter Highlights

-- Due to general economic weakness and a slowdown in capital expenditures, revenue declined to $2.0 million with a GAAP net loss of $2.5 million.

-- Late in the quarter, the Company signed and closed its agreement with Alcatel Micro Machining Systems (AMMS) and Alcatel-Lucent to acquire their Deep Reactive Ion Etch (DRIE) and Plasma Enhanced Chemical Vapor Deposition (PECVD) products, and the related intellectual property.

-- Backlog increased during and subsequent to the end of the quarter and included new orders for its recently acquired DRIE systems.

-- The Company initiated a 10% reduction in its workforce and other measures to reduce spending during the coming quarter.

Financial Results

Revenues for the second quarter of fiscal 2009 were $2.0 million, a decrease of 81% from $10.8 million in the same period last year. Tegal reported a net loss of ($2.5) million, or ($0.34) per share, for the quarter, compared to net income of $0.7 million, or $0.10 per share in the same period last year, and a net loss of ($0.8) million, or ($0.11) per share in the prior quarter.
Gross profits for the second quarter of fiscal 2009 were 50.8% compared to 39.3% in the same period last year, and up from 49.2% in the prior quarter.

Operating loss for the second quarter was ($2.4) million, including approximately $0.5 million of non-cash charges. Operating income in the same period last year was $0.5 million. That period's operating expenses included $0.6 million of non-cash charges. The operating loss for Q1 of this fiscal year was ($1.0) million, which included $0.5 million of non-cash charges.

Backlog at the end of the quarter was $1.1 million, and is currently $3.3 million.

Cash at the end of the fiscal second quarter of 2009 was $14.0 million, a $4.2 million decrease from the end of the June quarter. Over the same three month period, inventories increased by $2.6 million to $13.7 million, related primarily to the acquisition.

Under the terms of the Asset Purchase Agreement with AMMS and Alcatel Lucent, dated September 2, 2008, Tegal paid $1,000,000 in cash and issued 1,044,386 shares of Tegal common stock at a value of $3.83 per share.

As of September 30, 2008, the Company's total shares outstanding were 8,321,496.

"During the final month of the quarter we signed and closed our acquisition of the DRIE and LTPECVD products from Alcatel, and we are pleased with our progress to date on integrating the acquisition," said Thomas Mika, President and CEO of Tegal Corporation. "We recently announced two system orders for both cluster and stand-alone versions of the DRIE systems, one of which has already been installed at our customer. These orders and a promising pipeline strengthen our belief in the long-term prospects for this business and we will pursue this opportunity aggressively. During the quarter, we took measures to reduce our workforce and other expenses, while preserving our ability to properly transition and support our key growth opportunities. In the current tougher economic environment, we believe these steps, along with all of the profitability initiatives we have made in recent years, will help position the Company to weather the storm and emerge as a stronger company. We believe that so long as the business environment does not significantly worsen, we can improve our results measurably on a sequential basis and we look forward to an improved financial forecast in the coming quarters."

Investor Conference Call

Tegal Corporation will discuss these results and further details of its second quarter of fiscal 2009 during a conference call today, November 13, 2008, at 5:00 p.m. EST / 2:00 p.m. PST. The call is open to all interested investors. The call-in numbers are (866) 510-0711 or (617) 597-5379. For either dial-in number, Investors should reference passcode: 90211158. A digital recording will be made available two hours after the completion of the conference call, and it will be accessible through midnight on Thursday, November 20, 2008. To access, investors should dial (888) 286-8010 or (617) 801-6888 and enter passcode: 50476559. The conference call also will be available online via the Investor Section of the Company's website at: www.tegal.com. An online replay of the teleconference, along with a copy of the Company's earnings release, will also be available on the Company's website.

Safe Harbor Statement

Except for historical information, matters discussed in this news release contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements, which are based on assumptions and describe our future plans, strategies and expectations, are generally identifiable by the use of the words "anticipate," "believe," "estimate," "expect," "intend," "project" or similar expressions. These forward-looking statements are subject to risks, uncertainties and assumptions about the Company including, but not limited to industry conditions, economic conditions, acceptance of new technologies and market acceptance of the Company's products and services. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements in this paragraph. For a further discussion of these risks and uncertainties, please refer to the Company's periodic filings with the Securities and Exchange Commission.

####

About Tegal Corporation
Tegal provides process and equipment solutions to leading edge suppliers of advanced semiconductor and nanotechnology devices. Incorporating unique, patented etch and deposition technologies, Tegal's system solutions are backed by over 35 years of advanced development and over 100 patents. Some examples of devices enabled by Tegal technology are energy efficient memories found in portable computers, cellphones, PDAs and RFID applications; megapixel imaging chips used in digital and cellphone cameras; power amplifiers for portable handsets and wireless networking gear; and MEMS devices like accelerometers for automotive airbags, microfluidic control devices for ink jet printers; and laboratory-on-a-chip medical test kits.

TEGAL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except share data)
                                                                           September, 30              March 31,
                                                                                 2008                       2008
ASSETS
Current assets:
Cash and cash equivalents                                                  $     14,017               $     19,271
Accounts receivable, net of allowances for sales returns and                     4,609                      6,758
doubtful accounts of $213 and $191 at September 30, 2008 and March
31, 2008, respectively
Inventories, net                                                                 13,690                     11,056
Prepaid expenses and other current assets                                        659                        788
Total current assets                                                             32,975                     37,873
Property and equipment, net                                                      1,210                      1,213
Intangible assets, net                                                           3,856                      903
Other assets                                                                     75                         90
Total assets                                                               $     38,116               $     40,079
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Notes payable and bank lines of credit                                     $     6                    $     14
Accounts payable                                                                 602                        1,469
Accrued product warranty                                                         947                        1,770
Deferred revenue                                                                 260                        252
Accrued expenses and other current liabilities                                   1,966                      3,644
Total current liabilities                                                        3,781                      7,149
Total liabilities                                                                3,781                      7,149
Commitments and contingencies (Note 7)
Stockholders' equity:
Preferred stock; $0.01 par value; 5,000,000 shares authorized; none              --                         --
issued and outstanding
Common stock; $0.01 par value; 50,000,000 shares authorized;                     83                         72
8,321,496 and 7,242,736 shares issued and outstanding at September
30, 2008 and March 31, 2008, respectively
Additional paid-in capital                                                       128,217                    123,567
Accumulated other comprehensive income (loss)                                    (412     )                 (446     )
Accumulated deficit                                                              (93,553  )                 (90,263  )
Total stockholders' equity                                                       34,335                     32,930
Total liabilities and stockholders' equity                                 $     38,116               $     40,079


TEGAL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except per share data)
                                             Three Months Ended                            Six Months Ended
                                             September 30                                  September 30
                                                   2008                      2007                2008                      2007
Revenue                                      $     2,010               $     10,800        $     6,739               $     15,398
Cost of sales                                      989                       6,560               3,391                     9,537
Gross profit                                       1,021                     4,240               3,348                     5,861
Operating expenses:
Research and development expenses                  1,145                     1,057               2,281                     1,835
Sales and marketing expenses                       839                       1,279               1,682                     2,285
General and administrative expenses                1,471                     1,448               2,801                     2,651
Total operating expenses                           3,455                     3,784               6,764                     6,771
Operating income (loss)                            (2,434  )                 456                 (3,415  )                 (910    )
Other income (expense), net                        (65     )                 237                 125                       964
Net income (loss)                            $     (2,499  )           $     693           $     (3,290  )           $     54
Net income (loss) per share:
Basic                                        $     (0.34   )           $     0.10          $     (0.45   )           $     0.01
Diluted                                      $     (0.34   )           $     0.10          $     (0.45   )           $     0.01
Shares used in per share computation:
Basic                                              7,339                     7,119               7,338                     7,111
Diluted                                            7,339                     7,276               7,338                     7,217
Note: Shares used in per share computation for Basic and Diluted
reflect a 12 to 1 reverse stock split effected by the Company on
July 25, 2006


For more information, please click here

Contacts:
Tegal Corporation
Christine Hergenrother (VP and CFO), 707-763-5600
or
The Blueshirt Group
Chris Danne
415-217-7722

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Chip Technology

'Exotic' material is like a switch when super thin April 18th, 2014

Scientists open door to better solar cells, superconductors and hard-drives: Research enhances understanding of materials interfaces April 14th, 2014

Obducat has launched a new generation of SINDRE® Nano Imprint production system April 11th, 2014

Scientists in Singapore develop novel ultra-fast electrical circuits using light-generated tunneling currents April 10th, 2014

Announcements

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Tools

Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

Scientists Capture Ultrafast Snapshots of Light-Driven Superconductivity: X-rays reveal how rapidly vanishing 'charge stripes' may be behind laser-induced high-temperature superconductivity April 16th, 2014

Aerotech X-Y ball-screw stage for economical high performance Planar positioning April 16th, 2014

Financial Reports

Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014

Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014

Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014

Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE